Patients with bone metastasis had higher serum IL-22 levels (Supplementary Figure S2F, p = 0.008), and patients with brain metastasis had lower IL-4 levels (Supplementary Figure S2G, p = 0.025). This evidence concerns the gene IL22 and bone metastasis.